secwatch.observer — SEC 8-K summary ====================================== Issuer: XWELL, Inc. (XWEL) CIK: 0001410428 Form: 8-K Filed at: 2023-05-15T23:59:59+00:00 Accession: 0001104659-23-060853 Event type: earnings Sentiment: negative Materiality: 0.65 Item codes: 2.02, 9.01 LLM model: deepseek-v4-flash:cloud@v2 XWELL Q1 revenue $7.1M, down 70% YoY; net loss widens to $5.5M -------------------------------------------------------------- - Total revenue $7.1M vs $24.0M in Q1 2022; XpresSpa revenue up >70% YoY but testing revenue ended. - Net loss attributable to common shareholders $5.5M vs $4.3M loss YoY; loss from operations $6.3M. - Cash and marketable securities $35.1M; no long-term debt; net working capital $30.8M. - New CFO Valerie Lightfoot appointed effective June 12, 2023; plans to open XpresSpa in Philadelphia and Abu Dhabi. - Biosurveillance partnership with Ginkgo expanded to include influenza monitoring; 9 stations operating. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1410428/000110465923060853/0001104659-23-060853-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1410428/000110465923060853/tm2315858d1_8k.htm HTML page: https://secwatch.observer/filing/0001104659-23-060853 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer